Understanding how certain drugs affect multiple myeloma based on genetic differences.
Revealing the cis-Regulatory Function of IMiDs in Multiple Myeloma”.
This study is looking at how certain genes might affect how well multiple myeloma patients respond to specific treatments, and it invites patients to share genetic samples to help understand why some people benefit from these drugs while others do not.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10980423 on NIH RePORTER |
What this research studies
This research investigates the role of specific genetic factors in how multiple myeloma patients respond to immunomodulatory imide drugs (IMiDs). By analyzing the binding of transcription factors to genomic regions, the study aims to identify why some patients benefit from these treatments while others do not. The approach involves examining the unique molecular subtypes of myeloma and how they interact with these drugs. Patients may be involved in providing genetic samples to help clarify these relationships.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with multiple myeloma, particularly those with specific genetic alterations.
Not a fit: Patients with non-multiple myeloma conditions or those who do not have identifiable genetic alterations related to the study may not benefit.
Why it matters
Potential benefit: If successful, this research could lead to more personalized treatment strategies for multiple myeloma, improving outcomes for patients.
How similar studies have performed: Previous research has shown promising results in understanding the genetic basis of drug responses in various cancers, indicating potential for success in this area as well.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Barwick, Benjamin Gabriel — Emory University
- Study coordinator: Barwick, Benjamin Gabriel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.